Diabetes
Care

Diabetes Care

EKF Diabetes Care strives to improve patient access to diabetes care techniques through the provision of affordable, easy-to-use technology, reducing the cost of long-term healthcare of the diabetic and pre-diabetic population.

Our diagnostics tests for HbA1c and glucose deliver fast and reliable results that provide both practitioner and patient with the information they need to make clinical or lifestyle decisions in minutes.

Glycated hemoglobin (HbA1c) has gathered momentum as the preferred method for monitoring diabetes within the medical community over the last decade.

EKF’s two HbA1c point-of-care analyzers, Quo-Test and Quo-Lab, are designed to deliver results that meet the requirements of NGSP and IFCC for point-of-care HbA1c analyzers within four minutes.

The Biosen C-Line and S-Line series of glucose analysers are a familiar brand name in laboratories and diabetes clinics. Biosen uses chip sensor technology to provide fast and highly accurate results at a low cost for glucose, and, if required, lactate.

STAT-Site M B-HB is a hand-held, strip-based analyzer intended for the quantitative determination of Beta-Hydroxybutyrate in serum or plasma to aid the diagnosis and monitoring ketoacidosis.

The EKF Diabetes Care portfolio also includes clinical chemistry used in diabetes care such as Beta-Hydroxybutyrate LiquiColor reagent, and Glycated Serum Protein which provides a two to three week indicator of average blood glucose.

EKF Diabetes Care strives to improve patient access to diabetes care techniques through the provision of affordable, easy-to-use technology.

cta-Diabetes.png